Bariatric surgery as potential treatment for nonalcoholic fatty liver disease: A future treatment by choice or by chance?

Journal of Obesity

Volumn 2013, Issue , 2013, Pages

  Hafeez, Shuja ^a   Ahmed, Mohamed H ^b  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

^b WEXHAM PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIOBESITY AGENT; OXYNTOMODULIN; PEPTIDE YY;

BARIATRIC SURGERY; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DYSLIPIDEMIA; FOLLOW UP; GASTRIC BANDING; HEPATITIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIVER CIRRHOSIS; LIVER FIBROSIS; METABOLIC SYNDROME X; MORBID OBESITY; NONALCOHOLIC FATTY LIVER; REVIEW; STEATOSIS; WEIGHT REDUCTION; FATTY LIVER; HYPERLIPIDEMIA; PATHOLOGY; STOMACH BYPASS;

BARIATRIC SURGERY; FATTY LIVER; GASTRIC BYPASS; HUMANS; HYPERLIPIDEMIAS; INFLAMMATION; INSULIN RESISTANCE; LIVER CIRRHOSIS; METABOLIC SYNDROME X; OBESITY, MORBID; WEIGHT LOSS;

MLCS; MLOWN;

EID: 84874597977     PISSN: 20900708     EISSN: 20900716     Source Type: Journal    
DOI: 10.1155/2013/839275     Document Type: Review

References (98)

1. Adams L. A., Angulo P., Treatment of non-alcoholic fatty liver disease. Postgraduate Medical Journal 2006 82 967 315 322 2-s2.0-33645536593 10.1136/pgmj.2005.042200 (Pubitemid 43780662)
2. Newburgh L. H., Conn J. W., A new interpretation of hyperglycemia in obese middle aged persons. The Journal of the American Medical Association 1939 112 7 11
3. Zelman S., The liver in obesity. A.M.A. Archives of Internal Medicine 1952 90 141 156
4. Ludwig J., Viggiano T. R., McGill D. B., Ott B. J., Nonalcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proceedings 1980 55 7 434 438 2-s2.0-0019152816 (Pubitemid 10057164)
5. Ahmed M. H., Byrne C. D., Byrne C. D., Wild S. H., Non-alcoholic fatty liver disease. The Metabolic Syndrome 2011 2nd Oxford, UK Wiley-Blackwell 245 277 10.1002/9781444347319.ch15
6. Angulo P., Medical progress: nonalcoholic fatty liver disease. The New England Journal of Medicine 2002 346 16 1221 1231 2-s2.0-0037129380 10.1056/NEJMra011775 (Pubitemid 34984585)
7. Sass D. A., Chang P., Chopra K. B., Nonalcoholic fatty liver disease: a clinical review. Digestive Diseases and Sciences 2005 50 1 171 180 2-s2.0-14544308375 10.1007/s10620-005-1267-z (Pubitemid 40379159)
8. Teli M. R., James O. F. W., Burt A. D., Bennett M. K., Day C. P., The natural history of nonalcoholic fatty liver: a follow-up study. Hepatology 1995 22 6 1714 1719 2-s2.0-0028875908
9. Alba L. M., Lindor K., Review article: non-alcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2003 17 8 977 986 2-s2.0-0038707252 10.1046/j.1365-2036.2003.01493.x (Pubitemid 36560797)
10. Anstee Q. M., McPherson S., Day C. P., How big a problem is non-alcoholic fatty liver disease? British Medical Journal 2011 343 7816, article d3897 2-s2.0-79960693457 10.1136/bmj.d3897
11. Edmison J., McCullough A. J., Pathogenesis of non-alcoholic steatohepatitis: human data. Clinics in Liver Disease 2007 11 1 75 104 2-s2.0-34249746761 10.1016/j.cld.2007.02.011 (Pubitemid 46829977)
12. Bugianesi E., Leone N., Vanni E., Marchesini G., Brunello F., Carucci P., Musso A., De Paolis P., Capussotti L., Salizzoni M., Rizzetto M., Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002 123 1 134 140 2-s2.0-0036302288 10.1053/gast.2002.34168 (Pubitemid 34747534)
13. Day C. P., Non-alcoholic fatty liver disease: current concepts and management strategies. Clinical Medicine 2006 6 1 19 25 2-s2.0-33644504852
14. Oneta C. M., Dufour J. F., Non-alcoholic fatty liver disease: treatment options based on pathogenic considerations. Swiss Medical Weekly 2002 132 35-36 493 505 2-s2.0-0037037292 (Pubitemid 35453274)
15. Preiss D., Sattar N., Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clinical Science 2008 115 5-6 141 150 2-s2.0-49649091383 10.1042/CS20070402
16. Sorbi D., Boynton J., Lindor K. D., The ratio of aspartate aminotransferase to alanine aminotransferase: potential value in differentiating nonalcoholic steatohepatitis from alcoholic liver disease. The American Journal of Gastroenterology 1999 94 4 1018 1022 2-s2.0-0033119425 10.1016/S0002- 9270(99)00061-1 (Pubitemid 29173621)
17. Neuschwander-Tetri B. A., Caldwell S. H., Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003 37 5 1202 1219 2-s2.0-0038644536 10.1053/jhep.2003.50193 (Pubitemid 36538699)
18. Setji T. L., Holland N. D., Sanders L. L., Pereira K. C., Diehl A. M., Brown A. J., Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 2006 91 5 1741 1747 2-s2.0-33646401803 10.1210/jc.2005-2774
19. Stefan N., Kantartzis K., Häring H. U., Causes and metabolic consequences of fatty liver. Endocrine Reviews 2008 29 7 939 960 2-s2.0-57349116780 10.1210/er.2008-0009
20. Silverman E. M., Sapala J. A., Appelman H. D., Regression of hepatic steatosis in morbidly obese persons after gastric bypass. American Journal of Clinical Pathology 1995 104 1 23 31 2-s2.0-0028998719
21. Clark J. M., Alkhuraishi A. R. A., Solga S. F., Alli P., Diehl A. M., Magnuson T. H., Roux-en-Y gastric bypass improves liver histology in patients with non-alcoholic fatty liver disease. Obesity Research 2005 13 7 1180 1186 2-s2.0-32044451685
22. Mattar S. G., Velcu L. M., Rabinovitz M., Demetris A. J., Krasinskas A. M., Barinas-Mitchell E., Eid G. M., Ramanathan R., Taylor D. S., Schauer P. R., Sugerman H. J., Wolfe B. M., Ascher N. L., Sarr M. G., Pellegrini C. A., Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome. Annals of Surgery 2005 242 4 610 620 2-s2.0-26444467171 10.1097/01.sla.0000179652.07502.3f (Pubitemid 41428657)
23. Mottin C. C., Moretto M., Padoin A. V., Kupski C., Swarowsky A. M., Glock L., Duval V., Braga Da Silva J., Histological behavior of hepatic steatosis in morbidly obese patients after weight loss induced by bariatric surgery. Obesity Surgery 2005 15 6 788 793 2-s2.0-21344458564 10.1381/0960892054222830 (Pubitemid 40904867)
24. Klein S., Mittendorfer B., Eagon J. C., Patterson B., Grant L., Feirt N., Seki E., Brenner D., Korenblat K., McCrea J., Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease. Gastroenterology 2006 130 6 1564 1572 2-s2.0-33646339636 10.1053/j.gastro.2006.01.042 (Pubitemid 43668832)
25. Barker K. B., Palekar N. A., Bowers S. P., Goldberg J. E., Pulcini J. P., Harrison S. A., Non-alcoholic steatohepatitis: effect of Roux-en-Y gastric bypass surgery. The American Journal of Gastroenterology 2006 101 2 368 373 2-s2.0-33644897589 10.1111/j.1572-0241.2006.00419.x (Pubitemid 43381682)
26. Csendes A., Smok G., Burgos A. M., Histological findings in the liver before and after gastric bypass. Obesity Surgery 2006 16 5 607 611 2-s2.0-33646861774 10.1381/096089206776944904 (Pubitemid 43781046)
27. de Almeida S. R., Rocha P. R. S., Sanches M. D., Leite V. H. R., da Silva R. A. P., Diniz M. T. C., Sander Diniz M. D. F. H., Savassi Rocha A. L., Roux-en-Y gastric bypass improves the nonalcoholic steatohepatitis (NASH) of morbid obesity. Obesity Surgery 2006 16 3 270 278 2-s2.0-33645283607 10.1381/096089206776116462
28. Furuya C. K. Jr., de Oliveira C. P. M. S., de Mello E. S., Faintuch J., Raskovski A., Matsuda M., Vezozzo D. C. P., Halpern A., Garrido A. B., Alves V. A. F., Carrilho F. J., Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years. Journal of Gastroenterology and Hepatology 2007 22 4 510 514 2-s2.0-33947247615 10.1111/j.1440-1746.2007.04833.x (Pubitemid 46434992)
29. Liu X., Lazenby A. J., Clements R. H., Jhala N., Abrams G. A., Resolution of nonalcoholic steatohepatits after gastric bypass surgery. Obesity Surgery 2007 17 4 486 492 2-s2.0-34249791215 10.1007/s11695-007-9086-2 (Pubitemid 46850188)
30. Weiner R. A., Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Digestive Diseases 2010 28 1 274 279 2-s2.0-77952579195 10.1159/000282102
31. Moretto M., Kupski C., da Silva V. D., Padoin A. V., Mottin C. C., Effect of bariatric surgery on liver fibrosis. Obesity Surgery 2012 22 7 1044 1049
32. Ranlov I., Hardt F., Regression of liver steatosis following gastroplasty or gastric bypass for morbid obesity. Digestion 1990 47 4 208 214 2-s2.0-0025549042
33. Jaskiewicz K., Raczynska S., Rzepko R., Sledziński Z., Nonalcoholic fatty liver disease treated by gastroplasty. Digestive Diseases and Sciences 2006 51 1 21 26 2-s2.0-30844454943 10.1007/s10620-006-3077-3 (Pubitemid 43106329)
34. Stratopoulos C., Papakonstantinou A., Terzis I., Spiliadi C., Dimitriades G., Komesidou V., Kitsanta P., Argyrakos T., Hadjiyannakis E., Changes in liver histology accompanying massive weight loss after gastroplasty for morbid obesity. Obesity Surgery 2005 15 8 1154 1160 2-s2.0-25844522508 10.1381/0960892055002239 (Pubitemid 41390214)
35. Dixon J. B., Bhathal P. S., Hughes N. R., O'Brien P. E., Nonalcoholic fatty liver disease: improvement in liver histological analysis with weight loss. Hepatology 2004 39 6 1647 1654 2-s2.0-2542546652 10.1002/hep.20251 (Pubitemid 38702666)
36. Dixon J. B., Bhathal P. S., O'Brien P. E., Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obesity Surgery 2006 16 10 1278 1286 2-s2.0-33750571872 10.1381/096089206778663805 (Pubitemid 44671797)
37. Mathurin P., Hollebecque A., Arnalsteen L., Buob D., Leteurtre E., Caiazzo R., Pigeyre M., Verkindt H., Dharancy S., Louvet A., Romon M., Pattou F., Prospective study of the long term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology 2009 137 2 532 540 2-s2.0-67650951419 10.1053/j.gastro.2009.04.052
38. Kral J. G., Thung S. N., Biron S., Hould F. S., Lebel S., Marceau S., Simard S., Marceau P., Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis. Surgery 2004 135 1 48 58 2-s2.0-0348047323 10.1016/j.surg.2003.10.003 (Pubitemid 38041453)
39. Keshishian A., Zahriya K., Willes E. B., Duodenal switch has no detrimental effects on hepatic function and improves hepatic steatohepatitis after 6 months. Obesity Surgery 2005 15 10 1418 1423 2-s2.0-28544448787 10.1381/096089205774859290 (Pubitemid 41746416)
40. Mottin C. C., Moretto M., Padoin A. V., Swarowsky A. M., Toneto M. G., Glock L., Repetto G., The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obesity Surgery 2004 14 5 635 637 2-s2.0-2642521468 10.1381/096089204323093408 (Pubitemid 38716583)
41. Saadeh S., Younossi Z. M., Remer E. M., Gramlich T., Ong J. P., Hurley M., Mullen K. D., Cooper J. N., Sheridan M. J., The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002 123 3 745 750 2-s2.0-0036729447 10.1053/gast.2002.35354 (Pubitemid 34977081)
42. Sanyal A. J., AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002 123 5 1705 1725 2-s2.0-0036829092 (Pubitemid 35231670)
43. Harrison S. A., Liver disease in patients with diabetes mellitus. Journal of Clinical Gastroenterology 2006 40 1 68 76 2-s2.0-33644888156 10.1097/01.mcg.0000190774.91875.d2 (Pubitemid 44378080)
44. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., Natale S., Vanni E., Villanova N., Melchionda N., Rizzetto M., Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003 37 4 917 923 2-s2.0-0037382786 10.1053/jhep.2003.50161 (Pubitemid 36397405)
45. McAvoy N. C., Ferguson J. W., Campbell I. W., Hayes P. C., Non-alcoholic fatty liver disease: natural history, pathogenesis and treatment. British Journal of Diabetes and Vascular Disease 2006 6 6 251 260 2-s2.0-33846299876 10.1177/14746514060060060201 (Pubitemid 46111467)
46. Fan J. G., Zhu J., Li X. J., Chen L., Li L., Dai F., Li F., Chen S. Y., Prevalence of and risk factors for fatty liver in a general population of Shanghai, China. Journal of Hepatology 2005 43 3 508 514 2-s2.0-23444451889 10.1016/j.jhep.2005.02.042 (Pubitemid 41111434)
47. Bellentani S., Marino M., Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD). Annals of Hepatology 2009 8 supplement 1 S4 S8 2-s2.0-66749106254
48. Luyckx F. H., Desaive C., Thiry A., Dewé W., Scheen A. J., Gielen J. E., Lefèbvrc P. J., Liver abnormalities in severely obese subjects: effect of drastic weight loss after gastroplasty. International Journal of Obesity 1998 22 3 222 226 2-s2.0-0031913573 (Pubitemid 28112021)
49. Tominaga K., Kurata J. H., Chen Y. K., Fujimoto E., Miyagawa S., Abe I., Kusano Y., Prevalence of fatty liver in Japanese children and relationship to obesity. An epidemiological ultrasonographic survey. Digestive Diseases and Sciences 1995 40 9 2002 2009 2-s2.0-0028810805 10.1007/BF02208670
50. Franzese A., Vajro P., Argenziano A., Puzziello A., Iannucci M. P., Saviano M. C., Brunetti F., Rubino A., Liver involvement in obese children: ultrasonography and liver enzyme levels at diagnosis and during follow-up in an Italian population. Digestive Diseases and Sciences 1997 42 7 1428 1432 2-s2.0-0030872385 10.1023/A:1018850223495 (Pubitemid 27339358)
51. Adams L. A., Lymp J. F., Sauver J. S., Sanderson S. O., Lindor K. D., Feldstein A., Angulo P., The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005 129 1 113 121 2-s2.0-22344452893 10.1053/j.gastro.2005.04.014 (Pubitemid 41002048)
52. Neuschwander-Tetri B. A., Brunt E. M., Wehmeier K. R., Oliver D., Bacon B. R., Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR- γ ligand rosiglitazone. Hepatology 2003 38 4 1008 1017 2-s2.0-0141532275 10.1053/jhep.2003.50420 (Pubitemid 37221684)
53. Bellentani S., Scaglioni F., Marino M., Bedogni G., Epidemiology of non-alcoholic fatty liver disease. Digestive Diseases 2010 28 1 155 161 2-s2.0-77952576769 10.1159/000282080
54. Hussein O., Grosovski M., Schlesinger S., Szvalb S., Assy N., Orlistat reverse fatty infiltration and improves hepatic fibrosis in obese patients with nonalcoholic steatohepatitis (NASH). Digestive Diseases and Sciences 2007 52 10 2512 2519 2-s2.0-34548477649 10.1007/s10620-006-9631-1 (Pubitemid 47373883)
55. Lingvay I., Raskin P., Szczepaniak L. S., Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes. Journal of Diabetes and its Complications 2007 21 3 137 142 2-s2.0-34247593406 10.1016/j.jdiacomp.2007.02.005 (Pubitemid 46687072)
56. Gomez E. V., de Miranda A. R., Oramas B. G., Soler E. A., Navarro R. L., Calzadilla Bertot L., Yasells Garcia A., Del Rosario Abreu Vazquez M., Clinical trial: a nutritional supplement Viusid, in combination with diet and exercise, in patients with nonalcoholic fatty liver disease. Alimentary Pharmacology and Therapeutics 2009 30 10 999 1009 2-s2.0-71949106750 10.1111/j.1365-2036.2009. 04122.x
57. Nobili V., Manco M., Devito R., Di Ciommo V., Comparcola D., Sartorelli M. R., Piemonte F., Marcellini M., Angulo P., Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 2008 48 1 119 128 2-s2.0-47149086771 10.1002/hep.22336 (Pubitemid 351975537)
58. Andersen T., Gluud C., Franzmann M. B., Christoffersen P., Hepatic effects of dietary weight loss in morbidly obese subjects. Journal of Hepatology 1991 12 2 224 229 2-s2.0-0025959287
59. Sjöström L., Lindroos A. K., Peltonen M., Torgerson J., Bouchard C., Carlsson B., Dahlgren S., Larsson B., Narbro K., Sjöström C. D., Sullivan M., Wedel H., Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. The New England Journal of Medicine 2004 351 2683 2693 (Pubitemid 39665322)
60. Adams T. D., Gress R. E., Smith S. C., Halverson R. C., Simper S. C., Rosamond W. D., LaMonte M. J., Stroup A. M., Hunt S. C., Long-term mortality after gastric bypass surgery. The New England Journal of Medicine 2007 357 8 753 761 2-s2.0-34548075820 10.1056/NEJMoa066603 (Pubitemid 47295642)
61. Sjöström L., Narbro K., Sjöström C. D., Karason K., Larsson B., Wedel H., Lystig T., Sullivan M., Bouchard C., Carlsson B., Bengtsson C., Dahlgren S., Gummesson A., Jacobson P., Karlsson J., Lindroos A. K., Lönroth H., Näslund I., Olbers T., Stenlöf K., Torgerson J., Ågren G., Carlsson L. M. S., Effects of bariatric surgery on mortality in Swedish obese subjects. The New England Journal of Medicine 2007 357 8 741 752 2-s2.0-34548090763 10.1056/NEJMoa066254 (Pubitemid 47295641)
62. Runkel N., Colombo-Benkmann M., Hüttl T. P., Tigges H., Mann O., Sauerland S., Clinical practice guideline: bariatric surgery. Deutsches Arzteblatt 2011 108 20 341 346 2-s2.0-79960334786 10.3238/arztebl.2011.0341
63. Brethauer S. A., Chand B., Schauer P. R., Risks and benefits of bariatric surgery: current evidence. Cleveland Clinic Journal of Medicine 2006 73 11 993 1007 2-s2.0-33750982411 10.3949/ccjm.73.11.993 (Pubitemid 44741672)
64. Ali M. R., Fuller W. D., Choi M. P., Wolfe B. M., Bariatric surgical outcomes. Surgical Clinics of North America 2005 85 4 835 852 2-s2.0-23244446409 10.1016/j.suc.2005.03.005 (Pubitemid 41095473)
65. Salem L., Jensen C. C., Flum D. R., Are bariatric surgical outcomes worth their cost? A systematic review. Journal of the American College of Surgeons 2005 200 2 270 278 2-s2.0-12444307088 10.1016/j.jamcollsurg.2004.09.045 (Pubitemid 40143219)
66. Nguyen N. T., Goldman C., Rosenquist C. J., Arango A., Cole C. J., Lee S. J., Wolfe B. M., Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Annals of Surgery 2001 234 3 279 291 2-s2.0-0034849468 10.1097/00000658-200109000-00002 (Pubitemid 32847065)
67. Buchwald H., Estok R., Fahrbach K., Banel D., Jensen M. D., Pories W. J., Bantle J. P., Sledge I., Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. The American Journal of Medicine 2009 122 3 248.e5 256.e5 2-s2.0-61549094077 10.1016/j.amjmed.2008.09.041
68. Karmali S., Schauer P., Birch D., Sharma A. M., Sherman V., Laparoscopic sleeve gastrectomy: an innovative new tool in the battle against the obesity epidemic in Canada. Canadian Journal of Surgery 2010 53 2 126 132 2-s2.0-77950816098
69. Schouten R., Wiryasaputra D. C., van Dielen F. M. H., van Gemert W. G., Greve J. W. M., Long-term results of bariatric restrictive procedures: a prospective study. Obesity Surgery 2010 20 12 1617 1626 2-s2.0-78651228113 10.1007/s11695-010-0211-2
70. Rabl C., Campos G. M., The impact of bariatric surgery on nonalcoholic steatohepatitis. Seminars in Liver Disease 2012 32 80 91
71. O'Brien P. E., Dixon J. B., Laurie C., Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomised trial. Annals of Internal Medicine 2006 144 625 633 (Pubitemid 46780646)
72. To V. T., Hüttl T. P., Lang R., Piotrowski K., Parhofer K. G., Changes in body weight, glucose homeostasis, lipid profiles, and metabolic syndrome after restrictive bariatric surgery. Experimental and Clinical Endocrinology & Diabetes 2012 120 9 547 552
73. Saboya C., Arasaki C. H., Matos D., Lopes-Filho G. J., Relationship between the preoperative body mass index and the resolution of metabolic syndrome following Roux-en-Y gastric bypass. Metabolic Syndrome and Related Disorders 2012 10 4 292 296
74. Júnior F. C. M., Júnior W. S., Filho N. S., Ferreira P. A., Araújo G. F., Mandarino N. R., Barbosa J. B., Lages J. S., Lima Jde R., Monteiro C. C., Effects of weight loss induced by bariatric surgery on the prevalence of metabolic syndrome. Arquivos Brasileiros de Cardiologia 2009 92 6 418 422, 435-439, 452-456
75. Inabnet W. B. III, Winegar D. A., Sherif B., Sarr M. G., Early outcomes of bariatric surgery in patients with metabolic syndrome: an analysis of the bariatric outcomes longitudinal database. Journal of the American College of Surgeons 2012 214 4 550 557
76. Bretón J. O., García B., Benito P., Gimeno S., García R., López P., Effect of gastric bypass on the metabolic syndrome and on cardiovascular risk. Nutrición Hospitalaria 2010 25 1 67 71
77. Pontiroli A. E., Laneri M., Veronelli A., Frigè F., Micheletto G., Folli F., Adami G., Scopinaro N., Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovascular Diabetology 2009 8, article 37 2-s2.0-69549118592 10.1186/1475-2840-8-37
78. Batsis J. A., Romero-Corral A., Collazo-Clavell M. L., Sarr M. G., Somers V. K., Lopez-Jimenez F., Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clinic Proceedings 2008 83 8 897 906 2-s2.0-49249115212 10.4065/83.8.897
79. Nugent C., Bai C., Elariny H., Gopalakrishnan P., Quigley C., Garone M., Afendy M., Chan O., Wheeler A., Afendy A., Younossi Z. M., Metabolic syndrome after laparoscopic bariatric surgery. Obesity Surgery 2008 18 10 1278 1286 2-s2.0-53849116815 10.1007/s11695-008-9511-1
80. Madan A. K., Orth W., Ternovits C. A., Tichansky D. S., Metabolic syndrome: yet another co-morbidity gastric bypass helps cure. Surgery for Obesity and Related Diseases 2006 2 1 48 51 2-s2.0-33646438528 10.1016/j.soard.2005.09.014
81. Lee W. J., Huang M. T., Wang W., Lin C. M., Chen T. C., Lai I. R., Effects of obesity surgery on the metabolic syndrome. Archives of Surgery 2004 139 10 1088 1092 2-s2.0-5444247120 10.1001/archsurg.139.10.1088 (Pubitemid 39362275)
82. Alexandrides T. K., Skroubis G., Kalfarentzos F., Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity. Obesity Surgery 2007 17 2 176 184 2-s2.0-34249857265 10.1007/s11695-007-9044-z (Pubitemid 47091578)
83. Skroubis G., Anesidis S., Kehagias I., Mead N., Vagenas K., Kalfarentzos F., Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obesity Surgery 2006 16 4 488 495 2-s2.0-33645735073 10.1381/096089206776327251
84. Angrisani L., Lorenzo M., Borrelli V., Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surgery for Obesity and Related Diseases 2007 3 2 127 132 2-s2.0-33947362934 10.1016/j.soard.2006.12.005 (Pubitemid 46444696)
85. Greenway S. E., Greenway F. L. III, Klein S., Effects of obesity surgery on non-insulin-dependent diabetes mellitus. Archives of Surgery 2002 137 10 1109 1117 2-s2.0-0036794143 (Pubitemid 35155242)
86. Carson J. L., Ruddy M. E., Duff A. E., Holmes N. J., Cody R. P., Brolin R. E., The effect of gastric bypass surgery on hypertension in morbidly obese patients. Archives of Internal Medicine 1994 154 2 193 200 2-s2.0-0028123449 10.1001/archinte.154.2.193 (Pubitemid 24032193)
87. Nguyen N. T., Varela E., Sabio A., Tran C. L., Stamos M., Wilson S. E., Resolution of hyperlipidemia after laparoscopic Roux en Y gastric bypass. Journal of the American College of Surgeons 2006 203 1 24 29 2-s2.0-33745209413 10.1016/j.jamcollsurg.2006.03.019
88. Brolin R. E., Bradley L. J., Wilson A. C., Cody R. P., Lipid risk profile and weight stability after gastric resective operations for morbid obesity. Journal of Gastrointestinal Surgery 2000 4 5 464 469 2-s2.0-0034263942
89. Ahmed M. H., Byrne C. D., Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation? Drug Discovery Today 2010 15 15-16 590 595 2-s2.0-77955517684 10.1016/j.drudis.2010.06.007
90. Byrne C. D., Olufad R., Bruce K. D., Cagampang F. R., Ahmed M. H., Metabolic disturbances in non-alcoholic fatty liver disease. Clinical Science 2009 116 7 539 564 2-s2.0-65549122652 10.1042/CS20080253
91. Ahmed M. H., Byrne C. D., Current treatment of non-alcoholic fatty liver disease. Diabetes, Obesity and Metabolism 2009 11 3 188 195 2-s2.0-59349107500 10.1111/j.1463-1326.2008.00926.x
92. Cnop M., Havel P. J., Utzschneider K. M., Carr D. B., Sinha M. K., Boyko E. J., Retzlaff B. M., Knopp R. H., Brunzell J. D., Kahn S. E., Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia 2003 46 4 459 469 2-s2.0-0038293399 (Pubitemid 36577787)
93. Hivert M. F., Sullivan L. M., Fox C. S., Nathan D. M., D'Agostino R. B., Wilson P. W. F., Meigs J. B., Associations of adiponectin, resistin, and tumor necrosis factor- α with insulin resistance. Journal of Clinical Endocrinology and Metabolism 2008 93 8 3165 3172 2-s2.0-49249138836 10.1210/jc.2008-0425
94. Pories W. J., Swanson M. S., MacDonald K. G., Long S. B., Morris P. G., Brown B. M., Barakat H. A., DeRamon R. A., Israel G., Dolezal J. M., Dohm L., MacLean L. D., Sugerman H. J., Mason E., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Annals of Surgery 1995 222 3 339 350 2-s2.0-0029130754
95. Buchwald H., Avidor Y., Braunwald E., Jensen M. D., Pories W., Fahrbach K., Schoelles K., Bariatric surgery: a systematic review and meta-analysis. The Journal of the American Medical Association 2004 292 14 1724 1737 2-s2.0-5044242948 10.1001/jama.292.14.1724 (Pubitemid 39346675)
96. Holdstock C., Lind L., Eden Engstrom B., Ohrvall M., Sundbom M., Larsson A., Karlsson F. A., CRP reduction following gastric bypass surgery is most pronounced in insulin-sensitive subjects. International Journal of Obesity 2005 29 10 1275 1280 2-s2.0-30544443731 10.1038/sj.ijo.0803000 (Pubitemid 43080308)
97. Vilarrasa N., Vendrell J., Sánchez-Santos R., Broch M., Megia A., Masdevall C., Gomez N., Soler J., Pujol J., Bettónica C., Aranda H., Gómez J. M., Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor- α receptors, C-reactive protein and adiponectin in morbidly obese patients. Clinical Endocrinology 2007 67 5 679 686 2-s2.0-35448992554 10.1111/j.1365-2265. 2007.02945.x (Pubitemid 47628468)
98. Drucker D. J., The role of gut hormones in glucose homeostasis. Journal of Clinical Investigation 2007 117 1 24 32 2-s2.0-33845998516 10.1172/JCI30076 (Pubitemid 46048446)